| 101431-5 | Mobility - Discharge Performance:-:RptPeriod:^Patient:-:CMS Assessment | 327 |
| 101432-3 | Mobility - OBRA/Interim Performance:-:RptPeriod:^Patient:-:CMS Assessment | 99 |
| 101435-6 | Referral:-:RptPeriod:^Patient:-:CMS Assessment | 13 |
| 101436-4 | Discharge Plan:-:RptPeriod:^Patient:-:CMS Assessment | 13 |
| 101438-0 | CHAMPS ped fall risk | 7 |
| 101447-1 | CASPR1 IgG + NF155 IgG4 pnl SerPl | 3 |
| 101455-4 | Mitochondrial metabolites panel SerPl | 20 |
| 101471-1 | Alpha globin gene deletion panel Bld | 3 |
| 101473-7 | Gas + Electrolytes Pnl BldV | 10 |
| 101474-5 | HAdV DNA + hMPV + Rhinovirus RNA pl Resp NAA+probe | 4 |
| 101505-6 | Bacterial Susc Pnl Bld Pos MIC.VOC det | 29 |
| 101506-4 | PEth panel Bld | 3 |
| 101542-9 | Bact vs viral etiol ind pnl SerPl | 2 |
| 101549-4 | Schmid fall risk | 8 |
| 101565-0 | Lytes Pnl BldV | 6 |
| 101568-4 | Thyroglob + Thyroglob Ab pnl Tiss FNA | 3 |
| 101569-2 | Spec | 34 |
| 101587-4 | H capsul H+ B derma Ag panel SerPl | 3 |
| 101591-6 | CMS - Identification Information:-:RptPeriod:^Patient:-:CMS Assessment | 149 |
| 101592-4 | CMS - Cognitive Patterns:-:RptPeriod:^Patient:-:CMS Assessment | 29 |
| 101594-0 | CMS - Mood:-:RptPeriod:^Patient:-:CMS Assessment | 30 |
| 101595-7 | CMS - Functional Abilities and Goals:-:RptPeriod:^Patient:-:CMS Assessment | 21 |
| 101596-5 | CMS - Prior functioning: everyday activities:-:RptPeriod:^Patient:-:CMS Assessment | 12 |
| 101598-1 | CMS - Functional Abilities and Goals - OBRA &or Interim:-:RptPeriod:^Patient:-:CMS Assessment | 2 |
| 101599-9 | CMS - Self-Care - OBRA/Interim Performance:-:RptPeriod:^Patient:-:CMS Assessment | 8 |
| 101600-5 | CMS - Mobility - OBRA/Interim Performance:-:RptPeriod:^Patient:-:CMS Assessment | 15 |
| 101601-3 | CMS - Active Diagnoses:-:RptPeriod:^Patient:-:CMS Assessment | 48 |
| 101602-1 | CMS - Health Conditions:-:RptPeriod:^Patient:-:CMS Assessment | 35 |
| 101603-9 | CMS - Pain assessment interview:-:RptPeriod:^Patient:-:CMS Assessment | 28 |
| 101604-7 | CMS - Swallowing &or Nutritional Status:-:RptPeriod:^Patient:-:CMS Assessment | 26 |
| 101606-2 | CMS - Oral &or Dental Status:-:RptPeriod:^Patient:-:CMS Assessment | 2 |
| 101607-0 | CMS - Skin Conditions:-:RptPeriod:^Patient:-:CMS Assessment | 27 |
| 101611-2 | CMS - Current number of unhealed pressure injuries at each stage:-:RptPeriod:^Patient:-:CMS Assessment | 63 |
| 101612-0 | CMS - High risk drug classes - use and indication:-:RptPeriod:^Patient:-:CMS Assessment | 10 |
| 101613-8 | CMS - Header - Special Treatments, Procedures, and Programs:-:RptPeriod:^Patient:-:CMS Assessment | 33 |
| 101614-6 | CMS - Special Treatments, Procedures, and Programs:-:RptPeriod:^Patient:-:CMS Assessment | 18 |
| 101615-3 | CMS - Header - Participation in Assessment and Goal Setting:-:RptPeriod:^Patient:-:CMS Assessment | 31 |
| 101617-9 | CMS - Discharge Plan:-:RptPeriod:^Patient:-:CMS Assessment | 4 |
| 101618-7 | CMS - Return to Community:-:RptPeriod:^Patient:-:CMS Assessment | 6 |
| 101619-5 | CMS - Referral:-:RptPeriod:^Patient:-:CMS Assessment | 5 |
| 101622-9 | CMS - Correction Request:-:RptPeriod:^Patient:-:CMS Assessment | 42 |
| 101626-0 | TG heterph Ab intrf panel Ser | 3 |
| 101629-4 | Hypoglycemia eval pnl SerPl | 6 |
| 101642-7 | Cardiovascular risk pnl SerPl | 9 |
| 101647-6 | Tick Pnl SerPlBld NAA+probe | 9 |
| 101652-6 | GH + Glc pst Glc stim pnl SerPl | 11 |
| 101653-4 | PHSP SerPl | 7 |
| 101654-2 | NEVAL Bld NB | 4 |
| 101655-9 | Basic metabolic and hematocrit pnl Bld | 16 |
| 101656-7 | Lactate & pyruvate pnl SerPlBld | 4 |